Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Role of p53 gene polymorphism and bladder cancer predisposition in northern India.

Srivastava P, Jaiswal PK, Singh V, Mittal RD.

Cancer Biomark. 2010-2011;8(1):21-8. doi: 10.3233/DMA-2011-0816.

PMID:
21896987
2.
3.

IL-8 -251 T > A polymorphism is associated with bladder cancer susceptibility and outcome after BCG immunotherapy in a northern Indian cohort.

Ahirwar DK, Mandhani A, Mittal RD.

Arch Med Res. 2010 Feb;41(2):97-103. doi: 10.1016/j.arcmed.2010.03.005.

PMID:
20470938
4.

Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.

Gangwar R, Mandhani A, Mittal RD.

Ann Surg Oncol. 2009 Jul;16(7):2028-34. doi: 10.1245/s10434-009-0488-3.

PMID:
19412632
5.

Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer.

Ahirwar D, Kesarwani P, Manchanda PK, Mandhani A, Mittal RD.

Cancer Genet Cytogenet. 2008 Jul;184(1):1-8. doi: 10.1016/j.cancergencyto.2008.02.015.

PMID:
18558283
6.

Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.

Jaiswal PK, Goel A, Mandhani A, Mittal RD.

Mol Biol Rep. 2012 May;39(5):5615-21. doi: 10.1007/s11033-011-1366-1.

PMID:
22193624
7.

XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.

Gangwar R, Mandhani A, Mittal RD.

J Cancer Res Clin Oncol. 2010 May;136(5):779-86. doi: 10.1007/s00432-009-0717-y.

PMID:
19924443
8.

Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India.

Gangwar R, Ahirwar D, Mandhani A, Mittal RD.

Urology. 2009 Mar;73(3):675-80. doi: 10.1016/j.urology.2008.09.043.

PMID:
19041121
9.
10.

Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.

Singh V, Srivastava P, Srivastava N, Kapoor R, Mittal RD.

Mol Biol Rep. 2012 Oct;39(10):9827-34. doi: 10.1007/s11033-012-1849-8.

PMID:
22733495
11.

Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.

Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, Wani S, Siddiqi M.

Cancer Genet Cytogenet. 2010 Dec;203(2):263-8. doi: 10.1016/j.cancergencyto.2010.08.010.

PMID:
21156242
12.
13.

Bladder cancer risk associated with genotypic polymorphism of the matrix metalloproteinase-1 and 7 in North Indian population.

Srivastava P, Gangwar R, Kapoor R, Mittal RD.

Dis Markers. 2010;29(1):37-46. doi: 10.3233/DMA-2010-0724.

14.

Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India.

Mittal RD, Srivastava DS, A M, B M.

Asian Pac J Cancer Prev. 2005 Jan-Mar;6(1):6-9.

15.

Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy.

Ahirwar DK, Mandhani A, Dharaskar A, Kesarwani P, Mittal RD.

BJU Int. 2009 Sep;104(6):867-73. doi: 10.1111/j.1464-410X.2009.08549.x.

16.

Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.

Jaiswal PK, Singh V, Mittal RD.

Mol Biol Rep. 2014 Feb;41(2):799-807. doi: 10.1007/s11033-013-2919-2.

PMID:
24390231
17.

Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.

Ahirwar D, Mandhani A, Mittal RD.

Arch Med Res. 2009 Feb;40(2):97-102. doi: 10.1016/j.arcmed.2008.11.006.

PMID:
19237018
18.

Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.

Ito M, Habuchi T, Watanabe J, Higashi S, Nishiyama H, Wang L, Tsuchiya N, Kamoto T, Ogawa O.

Urology. 2004 Jul;64(1):74-8.

PMID:
15245939
19.

Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.

Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, Bhatnagar A, Chintamani C, Sharma PC, Saxena S.

Cancer Detect Prev. 2009;32(5-6):386-94.

PMID:
19588543
20.

Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

Decobert M, Larue H, Bergeron A, Harel F, Pfister C, Rousseau F, Lacombe L, Fradet Y.

J Urol. 2006 Apr;175(4):1506-11.

PMID:
16516037
Items per page

Supplemental Content

Support Center